3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
3
Oligodendroglioma
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Melanoma
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Anus Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Splenomegaly
1
Skin Neoplasms
1
Interventions
Psychiatric Rehabilitation
2
Methylprednisolone
2
Immunologic Techniques
2
Flow Cytometry
2
Filgrastim
2
Alemtuzumab
2
sargramostim
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
camrelizumab
1
apatinib
1
aldesleukin
1
Thrombopoietin
1
Tacrolimus
1
Surveys and Questionnaires
1
Quality of Life
1
Prednisone
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Methods
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Interferon-alpha
1
Immunotherapy
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Granisetron
1
Gene Expression Profiling
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gestational Trophoblastic Disease
×
Quality of Life
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled